DE69629553D1 - Verfahren zur behandlung von interstitieller blasenentzündung mit hyaluronsäure - Google Patents

Verfahren zur behandlung von interstitieller blasenentzündung mit hyaluronsäure

Info

Publication number
DE69629553D1
DE69629553D1 DE69629553T DE69629553T DE69629553D1 DE 69629553 D1 DE69629553 D1 DE 69629553D1 DE 69629553 T DE69629553 T DE 69629553T DE 69629553 T DE69629553 T DE 69629553T DE 69629553 D1 DE69629553 D1 DE 69629553D1
Authority
DE
Germany
Prior art keywords
hyaluronic acid
treating interstitial
bladder inflammation
interstitial cystitis
interstitial bladder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69629553T
Other languages
English (en)
Other versions
DE69629553T2 (de
Inventor
Alvaro Morales
J Alkemade
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Teoranta
Original Assignee
Bioniche Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/388,038 external-priority patent/US5591724A/en
Application filed by Bioniche Inc filed Critical Bioniche Inc
Publication of DE69629553D1 publication Critical patent/DE69629553D1/de
Application granted granted Critical
Publication of DE69629553T2 publication Critical patent/DE69629553T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69629553T 1995-02-14 1996-02-14 Verfahren zur behandlung von interstitieller blasenentzündung mit hyaluronsäure Expired - Lifetime DE69629553T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/388,038 US5591724A (en) 1995-02-14 1995-02-14 Method for treating the urinary bladder and associated structures using hyaluronic acid
US388038 1995-02-14
US59101596A 1996-02-08 1996-02-08
US591015 1996-02-08
PCT/CA1996/000094 WO1996025168A1 (en) 1995-02-14 1996-02-14 Use of hyaluronic acid for the treatment of interstitial cystitis

Publications (2)

Publication Number Publication Date
DE69629553D1 true DE69629553D1 (de) 2003-09-25
DE69629553T2 DE69629553T2 (de) 2004-06-17

Family

ID=27012116

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69629553T Expired - Lifetime DE69629553T2 (de) 1995-02-14 1996-02-14 Verfahren zur behandlung von interstitieller blasenentzündung mit hyaluronsäure

Country Status (20)

Country Link
US (1) US5888986A (de)
EP (1) EP0813417B1 (de)
JP (1) JP4354528B2 (de)
KR (1) KR100268660B1 (de)
CN (1) CN1181016A (de)
AT (1) ATE247476T1 (de)
AU (1) AU705289B2 (de)
BR (1) BR9607601A (de)
CA (1) CA2203621C (de)
CZ (1) CZ288218B6 (de)
DE (1) DE69629553T2 (de)
DK (1) DK0813417T3 (de)
ES (1) ES2205013T3 (de)
HU (1) HUP9800467A3 (de)
IN (1) IN181358B (de)
NO (1) NO315842B1 (de)
NZ (1) NZ300903A (de)
PT (1) PT813417E (de)
TR (1) TR199700782T1 (de)
WO (1) WO1996025168A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2268476A1 (en) 1991-07-03 1998-04-30 Hyal Pharmaceutical Corporation Use of hyaluronan in gene therapy
US6548487B2 (en) 1996-12-27 2003-04-15 Seikagaku Corporation Agent for treatment of bladder troubles
CA2247389C (en) * 1996-12-27 2009-11-24 Seikagaku Corporation Agent for treatment of bladder troubles
DE69916643T2 (de) * 1998-10-22 2005-04-28 Bioniche Life Sciences Inc., London Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
MXPA02005842A (es) * 1999-12-13 2003-10-14 Bioniche Life Sciences Inc Oligonucleotidos sinteticos terapeuticamente utiles.
JP4215429B2 (ja) * 1999-12-28 2009-01-28 バイオニケ ライフ サイエンシーズ インコーポレイテッド 癌治療におけるヒアルロン酸
US7504387B2 (en) * 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
EP3556360A1 (de) * 2005-01-14 2019-10-23 Urigen, Inc. Zusammensetzungen zur behandlung von erkrankungen der unteren harnwege
DE102006060953A1 (de) 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
US8343942B2 (en) * 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
TWI516269B (zh) 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
TWI383796B (zh) 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
HUP0900717A3 (en) * 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US20110166098A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US8575130B2 (en) * 2010-01-04 2013-11-05 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US8449512B2 (en) 2010-04-09 2013-05-28 Davinci Biomedical Research Products Inc. Stoma stabilitating device and method
US9029347B2 (en) 2010-08-05 2015-05-12 Holy Stone Healthcare Co., Ltd. Method and mixture for treating and preventing inflammatory bowel disease
EP2545925B1 (de) 2011-07-12 2018-02-14 Holy Stone Healthcare Co.,Ltd. Zusammensetzung enthaltend Hyaluronsäure zur Behandlung und Verhinderung von Schleimhauterkrankungen
ITMI20111732A1 (it) * 2011-09-27 2013-03-28 Bsdpharma Srl Formulazioni farmaceutiche per la riduzione della sensibilizzazione crociata tra colon-retto ed il distretto urogenitale con mezzi non-farmacologici.
RU2519010C1 (ru) * 2013-03-20 2014-06-10 Общество с ограниченной ответственностью "КОЛЕТЕКС" Композиция для лечения цистита
WO2015018461A1 (fr) 2013-08-09 2015-02-12 Genbiotech Compositions therapeutiques comprenant d'acide hyaluronique
CN103655601B (zh) * 2013-12-31 2019-10-25 上海建华精细生物制品有限公司 一种用于膀胱灌洗的组合物
CN103861091B (zh) * 2014-03-20 2016-04-27 辽宁亿灵科创生物医药科技有限公司 治疗膀胱炎的药物组合物
WO2015154007A1 (en) * 2014-04-03 2015-10-08 Lipella Pharmaceuticals, Inc. Systems and methods of detecting interstitial cystitis
RU2557949C1 (ru) * 2014-08-14 2015-07-27 Общество с ограниченной ответственностью "КОЛЕТЕКС" Способ лечения лучевого и интерстициального цистита
EP3400951B1 (de) * 2017-05-12 2019-12-11 Farco-Pharma GmbH Blaseninstillationszusammensetzung enthaltend chondoitinsulfat (4,5 mg/ml), hyaluronsäure (16 mg/ml) und phosphatpuffer (ph 6,1 bis 7,9) mit erhöhter lagerstabiliät zur behandlung von cystitis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4296104A (en) * 1979-08-30 1981-10-20 Herschler R J Therapeutic dimethyl sulfoxide composition and methods of use
US4302577A (en) * 1979-10-05 1981-11-24 Biomed Research Inc. Process for preparing CSA or CSC
US5180715A (en) * 1980-11-17 1993-01-19 The Regents Of The University Of California Irrigation of internal bladder surfaces in mammals with sodium pentosanpolysulfate
DE3118588C2 (de) * 1981-05-11 1983-07-07 Luitpold-Werk, Chemisch-Pharmazeutische Fabrik, 8000 München Verfahren zur Herstellung eines injizierbaren hochreinen Chondroitinpolysulfates, hiernach erhältliches Produkt und pharmazeutische Zusammensetzung
US4640912A (en) * 1983-06-09 1987-02-03 Hausman Marvin S Administration of "active" chondroitin sulfate A and "active" chondroitin sulfate C or mixtures thereof to mammals including humans
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
ES2150427T3 (es) * 1992-06-02 2000-12-01 Bard Inc C R Procedimiento y dispositivo de implante para el suministro de farmacos a largo plazo.
JP2995090B2 (ja) * 1993-03-19 1999-12-27 キユー・メド・アクチエボラーグ 組織増大のための組成物および方法

Also Published As

Publication number Publication date
JPH10513476A (ja) 1998-12-22
JP4354528B2 (ja) 2009-10-28
CZ288218B6 (en) 2001-05-16
US5888986A (en) 1999-03-30
CA2203621C (en) 1998-04-28
NZ300903A (en) 1999-07-29
HUP9800467A3 (en) 1999-01-28
WO1996025168A1 (en) 1996-08-22
CN1181016A (zh) 1998-05-06
PT813417E (pt) 2003-12-31
AU705289B2 (en) 1999-05-20
MX9706182A (es) 1998-07-31
ATE247476T1 (de) 2003-09-15
KR100268660B1 (ko) 2000-10-16
HUP9800467A2 (hu) 1998-06-29
NO973732L (no) 1997-10-10
CZ257497A3 (cs) 1998-01-14
TR199700782T1 (xx) 1998-03-21
AU4617996A (en) 1996-09-04
EP0813417A1 (de) 1997-12-29
KR19980702251A (ko) 1998-07-15
DE69629553T2 (de) 2004-06-17
DK0813417T3 (da) 2003-11-03
EP0813417B1 (de) 2003-08-20
BR9607601A (pt) 1999-09-14
IN181358B (de) 1998-05-30
CA2203621A1 (en) 1996-08-22
ES2205013T3 (es) 2004-05-01
NO973732D0 (no) 1997-08-13
NO315842B1 (no) 2003-11-03

Similar Documents

Publication Publication Date Title
ATE247476T1 (de) Verfahren zur behandlung von interstitieller blasenentzündung mit hyaluronsäure
PL338705A1 (en) Application of gaba analogues in preventing and treating gastrointestinal diseases
ZA988278B (en) Ionic polymers as toxin-binding agents
IL123500A0 (en) Composite biomaterials for preventing post-surgical adhesions of tissues
IL138979A0 (en) Use of cannabinoids as anti-inflammatory agents
ATE232093T1 (de) Verwendung von fumarsäurederivaten zur behandlung von autoimmunerkrankungen
WO2002056895A3 (en) Ionene polymers and their use in treating mucositis
ATE193443T1 (de) Verwendung eines imidazols zur herstellung eines medikamentes zur behandlung der arteriosklerose
ATE231722T1 (de) Verfahren zur vermeidung von skelettproblemen beim geflügel
ATE261307T1 (de) Verwendung von misoprostol und/oder misoprostolsäure zur behandlung von erektionsstörungen
BR8907770A (pt) Solucao para tratamento de metal,solucao aquosa e processo para tratar uma superficie de metal
ATE248592T1 (de) Verwendung von naaladase hemmern zur herstellung eines medikaments zur behandlung von bestimmten krankheiten
DE69721747D1 (de) Methode zur behandlung oder verhütung von interstitieller blasenentzundung
ATE264674T1 (de) Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung
Hølund et al. The value of hyaluronidase treatment of different tissues before demonstration of fibronectin by the indirect immunoperoxidase technique
FI962549A0 (fi) Metallinen siirrännäinen ja menetelmä metallisen siirrännäisen käsittelemiseksi
DE69835210D1 (de) Verwendung von hyaluronidase zur herstellung eines arzneimittels zur behandlung von entzündungen
DE69428120T2 (de) Lokal anwendbares präparat zur reepithelisierung bei andauernden epitheldefekten
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
RU97115451A (ru) Способ лечения интерстициального цистита
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine
DE69732851D1 (de) Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren
MXPA02004704A (es) Analogos de acido hidroxieicosatetraenoico y sus metodos de uso en el tratamiento de trastornos de resequedad del ojo.
ATE224729T1 (de) Verwendung von hyaluronidase
RU96118184A (ru) Способ лечения рефлекторных синдромов при остеохондрозе

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIONICHE TEORANTA, GALWAY, IR